PolyPid to Report Third Quarter 2026 Financial Results and Operational Highlights on November 11, 2026
Key Highlights
- ➤PolyPid will report Q3 2026 financial results before U.S. markets open November 11, 2026
- ➤Conference call and webcast scheduled for 8:30 AM Eastern Time November 11
- ➤D-PLEX₁₀₀ met primary and all key secondary endpoints in Phase 3 SHIELD II trial
PETACH TIKVA, Israel, Oct. 29, 2026 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), an innovative biopharmaceutical company dedicated to improving patient outcomes by elevating treatment effectiveness, right where care begins, today announced that it will report its third quarter 2026 financial results and operational highlights before the open of the U.S. financial markets on Wednesday, November 11, 2026. The Company will host a conference call and webcast at 8:30 AM Eastern Time to discuss the results and provide an update on business operations.
To ensure you are connected prior to the beginning of the call, PolyPid suggests registering a minimum of 5 minutes before the start of the call. For those not planning to ask a question of management, the Company recommends listening via the webcast.
Get started
Create a free account to read the full story.